Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Popliteal nerve block including liposomal bupivacaine

Small molecule

Phase 4 Most advanced trial
1 Registered trials

What is Popliteal nerve block including liposomal bupivacaine?

Popliteal nerve block including liposomal bupivacaine is a regional anesthetic regimen in which unencapsulated bupivacaine 0.375% and liposomal bupivacaine 1.33% (Exparel) are admixed and injected for a popliteal nerve block. It is studied for pain control in moderate-to-severely painful ankle surgery.

Summary written with AI from the sources listed at the end of this page.

At a glance

Drug type
Small molecule
Therapy area
Oncology
In trials of
PCRX
FDA status
Investigational, not approved in the US. Most advanced trial: Phase 4

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT06995352 Phase 4 Moderate-to-severely Painful Ankle Surgery Enrolling by invitation PCRX

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Moderate-to-severely Painful Ankle Surgery

Sources

Updated Oct 25, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.